Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,094 | 252 | 99.9% |
| Education | $2.80 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $625.46 | 36 | $0 (2024) |
| Novo Nordisk Inc | $606.51 | 40 | $0 (2024) |
| Lilly USA, LLC | $402.21 | 23 | $0 (2024) |
| PFIZER INC. | $390.80 | 26 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $269.28 | 25 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $245.43 | 14 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $185.40 | 11 | $0 (2019) |
| Gilead Sciences, Inc. | $170.01 | 7 | $0 (2019) |
| GlaxoSmithKline, LLC. | $135.99 | 7 | $0 (2024) |
| Exact Sciences Corporation | $122.03 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $379.04 | 18 | Lilly USA, LLC ($61.85) |
| 2023 | $213.93 | 10 | Exact Sciences Corporation ($65.74) |
| 2022 | $31.41 | 1 | PFIZER INC. ($31.41) |
| 2020 | $235.95 | 14 | Lilly USA, LLC ($51.44) |
| 2019 | $1,075 | 74 | Novo Nordisk Inc ($174.58) |
| 2018 | $1,202 | 79 | Novo Nordisk Inc ($206.21) |
| 2017 | $959.21 | 57 | AstraZeneca Pharmaceuticals LP ($231.17) |
All Payment Transactions
253 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Endocrinology | ||||||
| 11/06/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $33.65 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: VACCINES | ||||||
| 09/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: Diabetes Care | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Respiratory | ||||||
| 07/17/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: VACCINES | ||||||
| 05/01/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: VACCINES | ||||||
| 04/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Diabetes | ||||||
| 03/20/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Hepatitis B Vaccine | ||||||
| 03/20/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Hepatitis B Vaccine | ||||||
| 03/06/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Oncology | ||||||
| 02/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Respiratory | ||||||
| 02/14/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Diabetes | ||||||
| 02/06/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: Endocrinology | ||||||
| 12/20/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.74 | General |
| Category: Oncology | ||||||
| 11/07/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Diabetes Care | ||||||
| 10/11/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Diabetes | ||||||
| 09/20/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Diabetes | ||||||
| 08/09/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Oncology | ||||||
| 07/26/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 582 | 664 | $226,304 | $58,730 |
| 2022 | 9 | 521 | 612 | $200,442 | $49,645 |
| 2021 | 10 | 529 | 611 | $186,765 | $49,327 |
| 2020 | 11 | 467 | 545 | $99,540 | $38,364 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 148 | 148 | $59,940 | $20,523 | 34.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 142 | 200 | $80,000 | $12,462 | 15.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 43 | 43 | $36,636 | $12,092 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 89 | $25,039 | $3,791 | 15.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 46 | 47 | $10,110 | $3,357 | 33.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 18 | 18 | $9,324 | $3,189 | 34.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 54 | 55 | $2,695 | $1,788 | 66.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 40 | 40 | $1,960 | $1,300 | 66.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 21 | 24 | $600.00 | $228.48 | 38.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 140 | 140 | $59,500 | $19,559 | 32.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 125 | 162 | $67,392 | $11,903 | 17.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 98 | 152 | $44,911 | $8,225 | 18.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 13 | 13 | $10,848 | $3,620 | 33.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 42 | 42 | $8,456 | $2,875 | 34.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 55 | 55 | $2,695 | $1,748 | 64.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 17 | 17 | $4,934 | $864.93 | 17.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 18 | 18 | $882.00 | $576.13 | 65.3% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 13 | 13 | $824.00 | $273.61 | 33.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 131 | 131 | $53,987 | $18,720 | 34.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 145 | 199 | $80,035 | $16,615 | 20.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 82 | 107 | $30,392 | $6,504 | 21.4% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 44 | 44 | $7,808 | $2,854 | 36.6% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 13 | 13 | $4,320 | $1,613 | 37.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 15 | 18 | $5,270 | $1,270 | 24.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 54 | 54 | $2,646 | $992.17 | 37.5% |
About Dr. Jonathan Mccoy, MD
Dr. Jonathan Mccoy, MD is a Family Medicine healthcare provider based in Hanover, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700815313.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Mccoy, MD has received a total of $4,097 in payments from pharmaceutical and medical device companies, with $379.04 received in 2024. These payments were reported across 253 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($4,094).
As a Medicare-enrolled provider, Mccoy has provided services to 2,099 Medicare beneficiaries, totaling 2,432 services with total Medicare billing of $196,066. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Hanover, MD
- Active Since 07/03/2006
- Last Updated 09/29/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1700815313
Products in Payments
- FARXIGA (Drug) $484.28
- Ozempic (Drug) $261.85
- CHANTIX (Drug) $206.38
- TRULICITY (Drug) $167.67
- TOUJEO (Drug) $160.70
- JANUVIA (Drug) $147.41
- Cologuard Collection Kit (Device) $122.03
- Victoza (Drug) $115.06
- EMGALITY (Drug) $108.39
- ENTRESTO (Drug) $101.21
- Trintellix (Drug) $99.64
- LYRICA (Drug) $89.56
- Xultophy 100/3.6 (Drug) $71.33
- INVOKANA (Drug) $67.09
- STIOLTO RESPIMAT (Drug) $63.98
- VIBERZI (Drug) $63.66
- SYMBICORT (Drug) $63.45
- MOUNJARO (Drug) $61.85
- PNEUMOVAX 23 (Biological) $59.00
- STIOLTO (Drug) $53.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hanover
Surender Singh, Md, MD
Family Medicine — Payments: $18,727
Dr. John Lunsford, M.d, M.D
Family Medicine — Payments: $14,039
Dr. Maureen Eisenberg, D.o, D.O
Family Medicine — Payments: $11,821
Dr. Jennifer Rein, M.d, M.D
Family Medicine — Payments: $9,338
Dr. Robert Henke, M.d, M.D
Family Medicine — Payments: $6,082
Esther Ajjarapu, Md, MD
Family Medicine — Payments: $4,657